Results 21 to 30 of about 371,981 (337)

A Double Blind Clinical Trial on the Efficacy of Honey Drop in Vernal Keratoconjunctivitis [PDF]

open access: yes, 2014
Purpose. This trial was designed to evaluate the efficacy and safety of topical honey eye drops in patients with diagnosed VKC. Methods. This clinical trial was conducted on 60 patients with diagnosed VKC.
Jabarzare, Solmaz.   +4 more
core   +3 more sources

A Patient with Corneal Epithelial Disorder That Developed after Administration of a Latanoprost Generic, but Not a Brand-Name Drug, Eye Drop

open access: yesCase Reports in Ophthalmological Medicine, 2012
Background. We report a patient who developed corneal epithelial disorder repeatedly after changing the prescription from Xalatan eye drops (Pfizer Inc.) to Latanoprost eye drops (Kaken Pharmaceutical Co., Ltd.), both containing 0.005% latanoprost. Case
Yukihisa Takada   +3 more
doaj   +1 more source

Hyaluronic Acid as an Alternative to Autologous Human Serum Eye Drops: Initial Clinical Results with High-Molecular-Weight Hyaluronic Acid Eye Drops

open access: yesCase Reports in Ophthalmology, 2019
Introduction: Autologous serum eye drops (ASED) are used in the treatment of most severe stages of dry eye. Once introduced, it is currently considered impossible to return to other lubricating eye drops or other commercially available therapeutic ...
Ria Beck   +5 more
doaj   +1 more source

Topical azithromycin or ofloxacin for endophthalmitis prophylaxis after intravitreal injection. [PDF]

open access: yes, 2014
Background: The number of patients who have undergone intravitreal injections has increased enormously in recent years, but a consensus is still lacking on prophylaxis for endophthalmitis.
Arias Barquet, Lluís   +4 more
core   +2 more sources

A Randomized, Double-Blinded, Placebo-Controlled, Cross Over Study Evaluating the Efficacy and Safety of Timolol Ophthalmic Solution as an Acute Treatment of Migraine [PDF]

open access: yes, 2020
Introduction. Daily oral beta-adrenoreceptor antagonist has been shown to be effective in preventing migraine headaches. Timolol 0.5% ophthalmic solution is a non-selective beta-adrenoreceptor antago- nist, where the primary use is for glaucoma.
Aggarwal, Dipika   +10 more
core   +2 more sources

Glaucoma, dementia and the 'precipice of care': transitions between states of medication adherence [PDF]

open access: yes, 2018
Purpose: “She wouldn’t remember. Even when I go through, and she’s decided to go to bed, I’ll say I’ll come and do her drops. If I didn’t say that, they wouldn’t be done.” Dementia is widely considered a key factor in whether patients take their ...
Harper, Robert   +5 more
core   +2 more sources

Long-Term Results after DMEK (Descemet’s Membrane Endothelial Keratoplasty) [PDF]

open access: yes, 2020
Ziel der Arbeit: Evaluation der langfristigen Ergebnisse sowie der Komplikationsrate nach Descemet’s Membran Endothelialen Keratoplastik (DMEK) Methoden: Eine cross-sectional, Fall-Serien Studie.
Wardeh, Rima
core   +1 more source

Comparative clinical evaluation of tacrolimus and cyclosporine eye drops for the treatment of canine keratoconjunctivitis sicca [PDF]

open access: yes, 2016
The aim of this study was to evaluate the efficacy of tacrolimus eye drops in alleviating the clinical symptoms of canine keratoconjunctivitis sicca (KCS) and to compare this efficacy with that of cyclosporine. The clinical study was conducted on 40 dogs
Balicki, Ireneusz   +1 more
core   +1 more source

Novel Eye Drop Delivery Systems: Advance on Formulation Design Strategies Targeting Anterior and Posterior Segments of the Eye

open access: yesPharmaceutics, 2022
Eye drops are the most common and convenient route of topical administration and the first choice of treatment for many ocular diseases. However, the ocular bioavailability of traditional eye drops (i.e., solutions, suspensions, and ointments) is very ...
Yaru Wang, Changhong Wang
doaj   +1 more source

Superglue mistaken for eye drops [PDF]

open access: yesArchives of Disease in Childhood, 2005
Cyanoacrylate, better known as superglue, is sold as a “do it yourself” (DIY) pack. The shape and colour of the superglue bottle in these packs bears a striking resemblance to the container of commonly used eye drops (fig 1). McLean reported accidental ocular injury from it in …
S P Desai, R Bhola, B C Teggihalli
openaire   +3 more sources

Home - About - Disclaimer - Privacy